Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
The Journal of Infectious Diseases|October 13, 2011
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.
Vaccine|May 31, 2011
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H Barouch, Sandra V Kik, Gerrit J Weverling, et al.
Vaccine|February 23, 2026
Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trialsAaron Hudson, Scott Borgetti, Anne-Marie Rick, et al.
JAMA Network Open|May 28, 2025
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical TrialsLeah I B Andrews, M Elizabeth Halloran, Kathleen M Neuzil, et al.
The New England Journal of Medicine|July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapyMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
Lancet (London, England)|February 16, 2010
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trialJairam R Lingappa, Jared M Baeten, Anna Wald, et al.
Eclinicalmedicine|August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group studyGuy de Bruyn, Joyce Wang, Annie Purvis, et al.
The Lancet. Infectious Diseases|January 29, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre studySaranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, et al.
Pageof 9